Effect of prostaglandin E2 on multidrug resistance transporters in Human Placental Cells

Drug Metabolism and Disposition

Volumn 42, Issue 12, 2014, Pages 2077-2086

  Mason, Clifford W ^a   Lee, Gene T ^a   Dong, Yafeng ^a   Zhou, Helen ^a   He, Lily ^a   Weiner, Carl P ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; FUMITREMORGIN C; HOE 33342; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; L 161982; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN; N [(5 BROMO 2 METHOXYPHENYL)SULFONYL] 3 [2 (2 NAPHTHYLMETHYL)PHENYL]ACRYLAMIDE; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RNA 18S; SULPROSTONE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VERAPAMIL; VERLUKAST; ABCG2 PROTEIN, HUMAN; CARRIER PROTEIN; MESSENGER RNA; PTGER1 PROTEIN, HUMAN; PTGER3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

CELL DIFFERENTIATION; CHORIOCARCINOMA CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME INHIBITION; ENZYME REPRESSION; FEMALE; GENE EXPRESSION REGULATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTRACELLULAR SIGNALING; LUCIFERASE ASSAY; PLACENTA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TROPHOBLAST; UPREGULATION; CELL LINE; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; PREGNANCY; SIGNAL TRANSDUCTION;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; DINOPROSTONE; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MEMBRANE TRANSPORT PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEINS; PLACENTA; PREGNANCY; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84909594869     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.114.059477     Document Type: Conference Paper

References (59)

1. Adam M, Boie Y, Rushmore TH, Müller G, Bastien L, McKee KT, Metters KM, and Abramovitz M (1994) Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett 338:170-174.
2. Agarwal S, Hartz AM, Elmquist WF, and Bauer B (2011) Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. Curr Pharm Des 17:2793-2802.
3. Arico S, Pattingre S, Bauvy C, Gane P, Barbat A, Codogno P, and Ogier-Denis E (2002) Celecoxib induces apoptosis by inhibiting 3-phosphoinositi de-depen dent protein kinase-1 activity in the human colon cancer HT-29 cell line. J Biol Chem 277:27613-27621.
4. Arroyo J, Torry RJ, and Torry DS (2004) Deferential regulation of placenta growth factor (P1GF)-mediated signal transduction in human primary term trophoblast and endothelial cells. Placenta 25:379-386.
5. Arunasree KM, Roy KR, Anilkumar K, Apama A, Reddy GV, and Reddanna P (2008) Imatinibresistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Leuk Res 32:855-864.
6. Atkinson DE, Greenwood SL, Sibley CP, Glazier JD, and Fairbaim LJ (2003) Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. Am J Physiol Cell Physiol 285:C584-C591.
7. Betz M and Fox BS (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146:108-113.
8. Bloise E, Bhuiyan M, Audette MC, Petropoulos S, Javam M, Gibb W, and Matthews SG (2013) Prenatal endotoxemia and placental drug transport in the mouse: placental size-specific effects. PLoS ONE 8:e65728.
9. Ceckova M, Libra A, Pavek P, Nachtigal P, Brabec M, Fuchs R, and Staud F (2006) Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin Exp Pharmacol Physiol 33:58-65.
10. Ceckova-Novotna M, Pavek P, and Staud F (2006) P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol 22:400-410.
11. Chen YH, Wang JP, Wang H, Sun MF, Wei LZ, Wei W, and Xu DX (2005) Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology 211:242-252.
12. Coles LD, Lee IJ, Voulalas PJ, and Eddington ND (2009) Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR). Mol Pharm 6:1816-1825.
13. de Vries NA, Zhao J, Kroon E, Buckle T, Beijnen JH, and van Tellingen O (2007) P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. Clin Cancer Res 13:6440-6449.
14. Díaz JF, Barasoain I, and Andreu JM (2003) Fast kinetics of Taxol binding to microtubules. Effects of solution variables and microtubule-associated proteins. J Biol Chem 278:8407-8419.
15. Dumoulin FL, Reichel C, Sauerbruch T, and Spengler U (1997) Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol 26:852-856.
16. Evseenko DA, Paxton JW, and Keelan JA (2006) ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290:R1357-R1365.
17. Evseenko DA, Paxton JW, and Keelan JA (2007) Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 35:595-601.
18. Fantappiè O, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A, and Mazzanti R (2002) The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 35:843-852.
19. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, Li Z, Evans DB, Abbruzzese JL, and Chiao PJ (2004) NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 24:7806-7819.
20. Furuta I, Yamada H, Sagawa T, and Fujimoto S (2000) Effects of inflammatory cytokines on prostaglandin E(2) production from human amnion cells cultured in serum-free condition. Gynecol Obstet Invest 49:93-97.
21. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, and Willoughby DA (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5:698-701.
22. Grigsby PL, Sooranna SR, Brockman DE, Johnson MR, and Myatt L (2006) Localization and expression of prostaglandin E2 receptors in human placenta and corresponding fetal membranes with labor. Am J Obstet Gynecol 195:260-269.
23. Guo R, Hou W, Dong Y, Yu Z, Stites J, and Weiner CP (2010) Brain injury caused by chronic fetal hypoxemia is mediated by inflammatory cascade activation. Reprod Sci 17:540-548.
24. Hata AN and Breyer RM (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103:147-166.
25. Ho EA and Piquette-Miller M (2006) Regulation of multidrug resistance by pro-inflammatory cytokines. Curr Cancer Drug Targets 6:295-311.
26. Hu SS, Bradshaw HB, Chen JS, Tan B, and Walker JM (2008) Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. Br J Pharmacol 153:1538-1549.
27. Jang SH, Wientjes MG, and Au JL (2001) Determinants of paclitaxel uptake, accumulation and retention in solid tumors. Invest New Drugs 19:113-123.
28. Kalalinia F, Elahian F, and Behravan J (2011) Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines. J Cancer Res Clin Oncol 137:321-330.
29. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, and Mitchell MD (2003) Cytokines, prostaglandins and parturition-a review. Placenta 24 (Suppl A):S33-S46.
30. Ko SH, Choi GJ, Lee JH, Han YA, Lim SJ, and Kim SH (2008) Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma. Oncol Rep 19:425-433.
31. Lagas JS, Vlaming ML, van Tellingen O, Wagenaar E, Jansen RS, Rosing H, Beijnen JH, and Schinkel AH (2006) Multi drug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics. Clin Cancer Res 12:6125-6132.
32. Liu B, Qu L, and Tao H (2010) Cyclo-oxygenase 2 up-regulates the effect of multidrug resistance. Cell Biol Int 34:21-25.
33. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
34. Llorente L, Richaud-Patin Y, Diaz-Borjon A, Alvarado de la Barrera C, Jakez-Ocampo J, de la Fuente H, Gonzalez-Amaro R, and Diaz-Jouanen E (2000) Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. Joint Bone Spine 67:30-39.
35. Mao Q (2008) BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm Res 25: 1244-1255.
36. Mason CW, Buhimschi IA, Buhimschi CS, Dong Y, Weiner CP, and Swaan PW (2011) ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition. Drug Metab Dispos 39:1000-1007.
37. Merino G, Jonker JW, Wagenaar E, van Herwaarden AE, and Schinkel AH (2005) The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin. Mol Pharmacol 67:1758-1764.
38. Myatt L (1990) Placental biosynthesis, metabolism, and transport of eicosanoids, in Eicosanoids in Reproduction (Mitchell MD, ed) pp 169-198, CRC Press Inc., Boca Raton, FL.
39. Negishi M, Sugimoto Y, and Ichikawa A (1995) Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta 1259:109-119.
40. Ogretmen B and Safa AR (1999) Negative regulation of MDR1 promoter activity in MCF-7, but not in multi drug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region. Biochemistry 38:2189-2199.
41. Patel VA, Dunn MJ, and Sorokin A (2002) Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem 277:38915-38920.
42. Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, and Schinkel AH (2005) Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther 312:144-152.
43. Petropoulos S, Gibb W, and Matthews SG (2010) Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse. Placenta 31:803-810.
44. Petrovic V, Teng S, and Piquette-Miller M (2007) Regulation of drug transporters during infection and inflammation. Mol Interv 7:99-111.
45. Petrovic V, Wang JH, and Piquette-Miller M (2008) Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 36: 1944-1950.
46. Pradhan M, Bembinster LA, Baumgarten SC, and Frasor J (2010) Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NFkappaB cooperativity at adjacent response elements. J Biol Chem 285: 31100-31106.
47. Premyslova M, Chisaka H, Okamura K, and Chal lis JR (2006) IL-1beta treatment does not coordinately up-regulate mPGES-1 and COX-2 mRNA expression, but results in higher degree of cellular and intracellular co-localization of their immunoreactive proteins in human placenta trophoblast cells. Placenta 27:576-586.
48. Roper RL and Phipps RP (1994) Prostaglandin E2 regulation of the immune response. Adv Prostaglandin Thromboxane Leukot Res 22:101-111.
49. Roy KR, Reddy GV, Maitreyi L, Agarwal S, Achari C, Vali S, and Reddanna P (2010) Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line. Cancer Chemother Pharmacol 65:903-911.
50. Schmid A, Thierauch KH, Schleuning WD, and Dinter H (1995) Splice variants of the human EP3 receptor for prostaglandin E2. Eur J Biochem 228:23-30.
51. Serrano MA, Macias RI, Briz O, Monte MJ, Blazquez AG, Williamson C, Kubitz R, and Marin JJ (2007) Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 28: 107-117.
52. Snijdewint FG, Kaliński P, Wierenga EA, Bos JD, and Kapsenberg ML (1993) Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 150:5321-5329.
53. Surowiak P, Pawelczyk K, Maciejczyk A, Pudelko M, Kolodziej J, Zabel M, Murawa D, Drag M, Gansukh T, and Dietel M, et al. (2008) Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer. Anticancer Res 28:2967-2974.
54. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, and Roach ML, et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100: 9044-9049.
55. Wang JH, Scollard DA, Teng S, Reilly RM, and Piquette-Miller M (2005) Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging. J Nucl Med 46: 1537-1545.
56. Yeboah D, Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, and Gibb W (2006) Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 84: 1251-1258.
57. Zatelli MC, Luchin A, Tagliati F, Leoni S, Piccin D, Bondanelli M, Rossi R, and degli Uberti EC (2007) Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. Endocr Relat Cancer 14: 1029-1038.
58. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, and Mao Q (2008) The breast cancer resistance protein (Bcrpl/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949-959.
59. Zrieki A, Farinotti R, and Buyse M (2008) Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm Res 25:1991-2001.